The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(2-aminopyridin-4-yl)-N-(3-cyanophenyl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxamide ID: ALA4781458
PubChem CID: 162664225
Max Phase: Preclinical
Molecular Formula: C22H19N5O2
Molecular Weight: 385.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cccc(NC(=O)N2CCOc3ccc(-c4ccnc(N)c4)cc3C2)c1
Standard InChI: InChI=1S/C22H19N5O2/c23-13-15-2-1-3-19(10-15)26-22(28)27-8-9-29-20-5-4-16(11-18(20)14-27)17-6-7-25-21(24)12-17/h1-7,10-12H,8-9,14H2,(H2,24,25)(H,26,28)
Standard InChI Key: PWFUQVAPDVWAQX-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
4.2166 -29.9348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2155 -30.7543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9235 -31.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9217 -29.5259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5093 -31.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8017 -30.7517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0941 -31.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0930 -31.9772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8054 -32.3862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5100 -31.9764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6351 -30.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6303 -29.9312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2713 -29.4102 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2851 -31.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0758 -29.5829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0881 -31.0698 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4371 -30.3222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6045 -31.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3141 -32.4671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4112 -31.5728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9275 -32.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6344 -32.9686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1500 -33.6017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9576 -33.4715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2470 -32.7028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7296 -32.0730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3869 -30.7496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0524 -32.5679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8586 -32.4346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 11 2 0
12 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 5 1 0
11 12 1 0
12 13 1 0
11 14 1 0
13 15 1 0
14 16 1 0
15 17 1 0
16 17 1 0
16 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
7 27 1 0
28 29 3 0
25 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.43Molecular Weight (Monoisotopic): 385.1539AlogP: 3.63#Rotatable Bonds: 2Polar Surface Area: 104.27Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.02CX Basic pKa: 6.89CX LogP: 2.77CX LogD: 2.66Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -1.43
References 1. Wilson JE,Kurukulasuriya R,Sinz C,Lombardo M,Bender K,Parker D,Sherer EC,Costa M,Dingley K,Li X,Mitelman S,Tong S,Bugianesi R,Ehrhardt A,Priest B,Ratliff K,Ujjainwalla F,Nargund R,Hagmann WK,Edmondson S. (2016) Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes., 26 (12.0): [PMID:27240550 ] [10.1016/j.bmcl.2016.04.018 ]